Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance

doi:10.4251/wjgo.v16.i9.3781

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (105)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-1)

Sum=103

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Sep 15, 2024 (publication date) through Sep 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3781-3797
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3781

Full Size Figure Download Figure

Figure 1 Timeline summary of erythropoietin-induced hepatocyte receptor A2-related research. Created by the BioRender. EphA2: Erythropoietin-induced hepatocyte receptor A; FDA: Food and Drug Administration; CML: Chronic myeloid leukemia; siRNA: Small interfering RNA; CAR-T: Chimeric antigen receptor T-cell therapy; HUVECs: Human umbilical vein endothelial cells.

Citation: Zhang YK, Shi R, Meng RY, Lin SL, Zheng M. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance. World J Gastrointest Oncol 2024; 16(9): 3781-3797
URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3781.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3781